Koers Endonovo Therapeutics Inc OTC Bulletin Board
Aandelen
US4111551044
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2021 | 0,07 0,07 | Omzet 2022 | 0,14 0,12 | Marktkapitalisatie | 3,5 mln. 3,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -3 mln. -2,74 mln. | Nettowinst (verlies) 2022 | -18 mln. -16,47 mln. | EV/omzet 2021 | 112.421.804 x |
Nettoschuld 2021 | 7,1 mln. 6,49 mln. | Nettoschuld 2022 | 7,15 mln. 6,54 mln. | EV/omzet 2022 | 78.689.579 x |
K/w-verhouding 2021 |
-0,3
x | K/w-verhouding 2022 |
-0,14
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 77,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alan Collier
CEO | Chief Executive Officer | 59 | 01-03-12 |
Steven Barnes
IRC | Investor Relations Contact | - | 01-05-14 |
Corporate Officer/Principal | 68 | 01-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Collier
CEO | Chief Executive Officer | 59 | 01-03-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,03% | 126 mld. | |
+23,61% | 117 mld. | |
+22,79% | 27,52 mld. | |
-18,07% | 20,87 mld. | |
-14,22% | 17,01 mld. | |
-14,81% | 16,26 mld. | |
+9,78% | 14,56 mld. | |
-46,10% | 15,09 mld. | |
+52,34% | 13,89 mld. |
- Beurs
- Aandelen
- Koers ENDV
- Koers